Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning

Michel, F; Solèr, M; Imhof, E; Perruchoud, A P
July 1991
Thorax;Jul1991, Vol. 46 Issue 7, p469
Academic Journal
journal article
No abstract available.


Related Articles

  • Skeletal Metastases In Apparently Operable Lung Cancer Evaluated With Whole Body Bone Scan -- A Pilot Study In South India. Shinto, Ajit S; Pachen, Leena; Sreekanth, T. K.; Joseph, C. D. // Internet Journal of Thoracic & Cardiovascular Surgery;2010, Vol. 14 Issue 2, p1 

    Study objectives: The management of patients diagnosed with non-small cell lung cancer is dependant on the stage of disease, which is also crucial for prognosis and selection of an appropriate treatment regimen. Historically a whole body bone scan has been used to identify skeletal metastases....

  • Is femoral uptake of Tc99m-methylene diphosphonate on bone scintigraphy in bronchogenic carcinoma an alarming sign: A case report and brief review of literature? Jung, Rayamajhi Sampanna; Mittal, Bhagwant Rai; Santhosh, Sampath; Sood, Ashwani; Bhattacharya, Anish; Kapoor, Rakesh // Lung India;Jul-Sep2014, Vol. 31 Issue 3, p280 

    Detection of skeletal metastasis in patients with lung cancer is important from management point of view. We report the bone scan finding in a patient with non-small cell lung carcinoma showing isolated abnormal tracer in femur and having a characteristic appearance in computed tomography,...

  • Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Schirrmeister, Holger; Arsiandemir, Coskun; Glatting, Gerhard; Mayer-Steinacker, Regine; Bommer, Martin; Dreinhöfer, Karsten; Buck, Andreas; Hetzel, Martin // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 7, p964 

    The leading European and American professional societies recommend that bone scans (BS) should be performed in the staging of lung cancer only in those patients with bone pain. This prospective study investigated the sensitivity of conventional skeletal scintigraphy in detecting osseous...

  • Best strategy for NSCLC staging?  // PharmacoEconomics & Outcomes News;2/1/2013, Issue 671, p9 

    The article discusses research being done on non-small cell lung cancer (NSCLC) staging, in reference to the study "The Optimality of Different Strategies For Supplemental Staging of Non-Small-Cell Lung Cancer: A Health Economic Decision Analysis" by R. Sogaard et al., in the January 2013 issue...

  • Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eschmann, S.; Friedel, G.; Paulsen, F.; Reimold, M.; Hehr, T.; Budach, W.; Scheiderbauer, J.; Machulla, H.; Dittmann, H.; Vonthein, R.; Bares, R. // European Journal of Nuclear Medicine & Molecular Imaging;Mar2006, Vol. 33 Issue 3, p389 

    A correction for the article "Is standardized 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?" that was published in the previous issue of the journal.

  • Cancer-Related Weight Loss. Palombine, Jessica // Clinical Journal of Oncology Nursing;Dec2006, Vol. 10 Issue 6, p831 

    Mr. A is a 70-year old man who was initially diagnosed with stage II colon cancer in 1990. Prior to diagnosis, he experienced an unintentional 23-pound weight loss. He underwent surgical resection, with additional surgery in 1992 for release of adhesions. He was treated with adjuvant...

  • Sentinel nodes in lung cancer: Review of our 10-year experience. Nomori, Hiroaki; Kohno, Mitsutomo; Izumi, Yotaro; Ohtsuka, Takashi; Asakura, Keisuke; Nakayama, Takashi // Surgery Today;Jul2011, Vol. 41 Issue 7, p889 

    Sentinel node (SN) identification in patients with lung cancer is useful not only to minimize lymph node dissection, but also to target the best lymph nodes for intraoperative frozen section during segmentectomy. Since 2000, we have identified the SN in lung cancer patients using radioisotope...

  • Advancements in Radiation Therapy for Medically Inoperable Early Stage Non-small Cell Lung Cancer. Kong, Feng-Ming (Spring); Chetty, Indrin J. // Current Medical Literature: Respiratory Medicine;2006, Vol. 20 Issue 3, p57 

    This section presents research which dealt with the advancements in radiation therapy for medically inoperable early stage of non-small cell lung cancer. Lung cancer is the most commonly detected cancer worldwide. In this regard, radiation therapy was proven to play an important role in the...

  • The Value of a Routine Bone Scan in a Metastatic Survey. Brown, Dale H.; Leakos, Mark // Journal of Otolaryngology;Jul/Aug1998, Vol. 27 Issue 4, p187 

    Evaluates the benefits of routine bone scanning preoperatively in patients with squamous cell carcinoma of the head and neck. Retrospective analysis of a number of patients undergoing a bone scan with respect to indication, diagnosis, scan result and tumor stage; Implication of the incidence of...

  • Necitumumab in NSCLC: value-based pricing.  // PharmacoEconomics & Outcomes News;Jul2015, Vol. 732 Issue 1, p23 

    The article reports on the value-based pricing and cost effectiveness of cancer drug necitumumab in patients with metastatic squamous cell nonsmall cell lung cancer (NSCLC).


Read the Article


Sign out of this library

Other Topics